ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 248

The Emotional Quotient in Fibromyalgia Patients Is Similar to Rheumatic Disease Controls

Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

There is IQ, the intelligence quotient, and EQ, the emotional quotient. EQ refers to emotional intelligence or the emotional intelligence quotient, the ability to use emotional information to guide thinking and behavior. It also refers to the ability to adjust emotions to achieve one’s goals

We wondered whether patients with fibromyalgia might have a poor emotional quotient and not be able to handle their symptoms well. We administered an in-office questionnaire to evaluate EQ.

Methods:

We administered an in-office questionnaire to patients with fibromyalgia and non-fibromyalgia rheumatic disease controls. Included were 10 questions, each graded 0-4, regarding social/emotional awareness. We compared the results from patients with fibromyalgia syndrome meeting the 2010 ACR criteria for the diagnosis and those with other rheumatic diseases.

Results:

There were 160 females and 31 males in the fibromyalgia syndrome group, and 82 females and 48 males in the non-fibromyalgia rheumatic disease patient group. The mean age of the fibromyalgia patients was 52.45 years for females and 50.39 years for males. The mean age of the patients with other rheumatic disease was 55.23 years for females and 54.02 years for males. 66.5% of the FMS patients and 57.7% of the no-FMS patients were married. The mean HAQ scores in FMS patients was 3.1 and in non-FMS rheumatic disease patients was 1.7 (p 0.001).

Patients with FMS had an emotional quotient scale of 33.0 compared with 32.0 for rheumatic disease controls, p 0.84. There was no statistically significant difference between the two groups.

Conclusion:

There was not a statistically significant difference between patients with fibromyalgia and non-FMS rheumatic disease patients with regard to their emotional quotient or social/emotional awareness.

It does not appear from the results of this study, that fibromyalgia patients are less equipped to handle their symptoms. Rather, their symptoms may overwhelm them because of the intensity, and not necessarily from an inability to cope with them emotionally.


Disclosure: R. S. Katz, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Polyak JL. The Emotional Quotient in Fibromyalgia Patients Is Similar to Rheumatic Disease Controls [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-emotional-quotient-in-fibromyalgia-patients-is-similar-to-rheumatic-disease-controls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-emotional-quotient-in-fibromyalgia-patients-is-similar-to-rheumatic-disease-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology